Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M110,544Revenue $M22,817Net Margin (%)21.0Altman Z-Score1.2
Enterprise Value $M154,057EPS $7.6Operating Margin %-13.6Piotroski F-Score6
P/E(ttm)35.5Beneish M-Score-2.5Pre-tax Margin (%)-20.5Higher ROA y-yY
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsN
Price/Sales4.85-y EBITDA Growth Rate %3.8Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow29.7y-y EBITDA Growth Rate %-22.6ROA % (ttm)3.6Higher Current Ratio y-yY
Dividend Yield %0.1PEG--ROE % (ttm)6.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M394ROIC % (ttm)-1.8Gross Margin Increase y-yY

Gurus Latest Trades with AGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGNVanguard Health Care Fund 2015-12-31 Add1.1%$253.04 - $322.49
($298.52)
$ 280.48-6%Add 19.27%10,962,347
AGNDavid Tepper 2015-12-31 Buy 0.93%$253.04 - $322.49
($298.52)
$ 280.48-6%New holding150,000
AGNFirst Eagle Investment 2015-12-31 Reduce-0.68%$253.04 - $322.49
($298.52)
$ 280.48-6%Reduce -59.91%669,995
AGNPrivate Capital 2015-12-31 Reduce-0.12%$253.04 - $322.49
($298.52)
$ 280.48-6%Reduce -2.12%166,017
AGNKen Fisher 2015-12-31 Add$253.04 - $322.49
($297.97)
$ 280.48-6%Add 3.80%3,306
AGNMario Gabelli 2015-12-31 Add$253.04 - $322.49
($298.52)
$ 280.48-6%Add 5.06%33,473
AGNChris Davis 2015-12-31 Sold Out $253.04 - $322.49
($298.52)
$ 280.48-6%Sold Out0
AGNDodge & Cox 2015-12-31 Sold Out $253.04 - $322.49
($298.52)
$ 280.48-6%Sold Out0
AGNGeorge Soros 2015-09-30 Add2.86%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 386.12%774,566
AGNWallace Weitz 2015-09-30 Buy 1.6%$252.1 - $339.5
($307.17)
$ 280.48-9%New holding187,607
AGNRuane Cunniff 2015-09-30 Buy 1.54%$252.1 - $339.5
($307.17)
$ 280.48-9%New holding1,103,395
AGNJulian Robertson 2015-09-30 Add0.55%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 34.16%59,700
AGNLeon Cooperman 2015-09-30 Reduce-0.54%$252.1 - $339.5
($307.17)
$ 280.48-9%Reduce -12.01%811,635
AGNSteve Mandel 2015-09-30 Add0.36%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 13.48%2,607,655
AGNPrivate Capital 2015-09-30 Add0.12%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 2.23%169,620
AGNFirst Eagle Investment 2015-09-30 Add0.09%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 8.07%1,671,156
AGNVanguard Health Care Fund 2015-09-30 Add0.09%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 1.69%9,190,927
AGNJohn Paulson 2015-09-30 Add0.01%$252.1 - $339.5
($307.17)
$ 280.48-9%Add 0.11%7,182,000
AGNMario Gabelli 2015-09-30 Reduce-0.01%$252.1 - $339.5
($307.17)
$ 280.48-9%Reduce -14.55%31,862
AGNKen Fisher 2015-09-30 Reduce$252.1 - $339.5
($307.17)
$ 280.48-9%Reduce -11.03%3,185
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Basgoz NesliDirector 2015-12-07Sell2,300$312.96-10.38view
BISARO PAULExec Chairman 2015-08-24Buy1,000$297.42-5.7view
SAUNDERS BRENT LCEO and President 2015-08-21Buy1,000$301.94-7.11view
Basgoz NesliDirector 2015-06-09Sell2,200$297.89-5.84view
Meury WilliamSee Remarks 2014-11-26Sell4,550$269.144.21view
PAONESSA ALBERT IIIPresident Anda, Inc. 2014-09-08Sell6,642$230.4921.69view
Hindman James M.EVP, Finance & Bus. Dev., CFO 2014-08-18Sell0$021.69view
Sherman Scott DExecutive Vice President, HR 2014-04-22Sell14,500$155.8280view
LAVIGNE LOUIS J JRDirector 2014-02-21Sell5,400$125.79122.97view
INGRAM DOUGLAS SPresident 2014-02-21Sell1$125.7123.13view

Press Releases about AGN :

Quarterly/Annual Reports about AGN:

    News about AGN:

    Articles On GuruFocus.com
    Vanguard Health Care Fund Sells Stake in Humana Feb 03 2016 
    Bill Ackman’s Fund Falls by Double Digits Again in January Feb 02 2016 
    Baron Funds Comments on Allergan Jan 27 2016 
    Bill Ackman's Pershing Square Annual Investor Letter Jan 27 2016 
    Dalio, Tepper, Klarman Ranked Best Hedge Fund Managers Jan 26 2016 
    Weitz Funds Comments on Allergan Jan 25 2016 
    Wallace Weitz Comments on Allergan Jan 22 2016 
    2 Stocks Super Investors Are Buying in Large Quantities Dec 26 2015 
    5 Top Stocks of the Outperforming Vanguard Health Care Fund Dec 28 2015 
    5 Guru Picks in Volatile Biotech Industry Dec 23 2015 

    More From Other Websites
    Loeb's Allergan Stake Grows by 50% Feb 12 2016
    ALLERGAN PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... Feb 12 2016
    Dan Loeb's Q4 trades Feb 12 2016
    Five Foreign Stocks Hedge Funds Love Feb 12 2016
    Inside the M&A Deals in the Health-Care Sector Feb 12 2016
    Eli Lilly loses latest round in UK drug patent battle Feb 12 2016
    Eli Lilly loses latest round in UK drug patent battle Feb 12 2016
    Napier Park is Betting Big on Media General (MEG) and Allergan (AGN) for 2016; Plus 3 Other Major... Feb 11 2016
    3 Value Stocks Ready to Outperform Feb 10 2016
    Allergan to Present at the RBC Capital Markets Healthcare Conference Feb 10 2016
    Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan) Feb 09 2016
    [$$] Pfizer seeks to soothe fears over R&D Feb 09 2016
    Pfizer To Reorganize After Allergan Buyout, With Saunders President Feb 08 2016
    Pfizer unveils management line up for combined company Feb 08 2016
    Pfizer unveils management line up for combined company Feb 08 2016
    [$$] Pfizer Outlines Post-Merger Management Slate Feb 08 2016
    Pfizer Names New Executives to Run Units After Allergan Deal Feb 08 2016
    Pfizer to create operating unit after Allergan deal closes Feb 08 2016
    Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan... Feb 08 2016
    Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan... Feb 08 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK